Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Pedemonte

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Annals of Neurology|August 9, 2007
Phenotypic characterization of hypomyelination and congenital cataractRoberta Biancheri, Federico Zara, Claudio Bruno, et al.
Annals of Neurology|June 23, 2019
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world dataMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Neuromuscular Disorders : NMD|December 1, 2022
Long term follow-up of scoliosis progression in type II SMA patientsGiorgia Coratti, Maria Carmela Pera, Adele D'Amico, et al.
Journal of Medical Genetics|August 2, 2020
Heterozygous <i>KIF1A</i> variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disordersFrancesco Nicita, Monia Ginevrino, Lorena Travaglini, et al.
The Journal of Pediatrics|February 10, 2020
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with NusinersenValeria A Sansone, Alice Pirola, Emilio Albamonte, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 22, 2023
Early treatment of type II SMA slows rate of progression of scoliosisGiorgia Coratti, Jacopo Lenkowicz, Maria Carmela Pera, et al.
Annals of Clinical and Translational Neurology|February 6, 2021
Type I SMA "new natural history": long-term data in nusinersen-treated patientsMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Annals of Clinical and Translational Neurology|February 15, 2022
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophyMarika Pane, Giorgia Coratti, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|March 28, 2021
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophyClaudia Brogna, Giorgia Coratti, Rachele Rossi, et al.
Neuropathology and Applied Neurobiology|July 29, 2022
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatmentChiara Fiorillo, Giovanna Capodivento, Alessandro Geroldi, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Annals of Neurology|August 9, 2007
Phenotypic characterization of hypomyelination and congenital cataractRoberta Biancheri, Federico Zara, Claudio Bruno, et al.
Annals of Neurology|June 23, 2019
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world dataMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Neuromuscular Disorders : NMD|December 1, 2022
Long term follow-up of scoliosis progression in type II SMA patientsGiorgia Coratti, Maria Carmela Pera, Adele D'Amico, et al.
Journal of Medical Genetics|August 2, 2020
Heterozygous <i>KIF1A</i> variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disordersFrancesco Nicita, Monia Ginevrino, Lorena Travaglini, et al.
The Journal of Pediatrics|February 10, 2020
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with NusinersenValeria A Sansone, Alice Pirola, Emilio Albamonte, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 22, 2023
Early treatment of type II SMA slows rate of progression of scoliosisGiorgia Coratti, Jacopo Lenkowicz, Maria Carmela Pera, et al.
Annals of Clinical and Translational Neurology|February 6, 2021
Type I SMA "new natural history": long-term data in nusinersen-treated patientsMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
Annals of Clinical and Translational Neurology|February 15, 2022
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophyMarika Pane, Giorgia Coratti, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|March 28, 2021
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophyClaudia Brogna, Giorgia Coratti, Rachele Rossi, et al.
Neuropathology and Applied Neurobiology|July 29, 2022
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatmentChiara Fiorillo, Giovanna Capodivento, Alessandro Geroldi, et al.
Pageof 8